Indian SME pharma firms see orders shift from China
In short
Small and mid-sized Indian pharma firms are getting more orders as some buyers move away from China. The reporting says Western buyers want to spread out supply chains, and India has lower labour costs and local raw materials.
This could help Indian suppliers, but they still depend on Chinese imports for key parts. It is not stated how long the shift will last or how big it is.
What the reporting says
Small and mid-sized Indian pharmaceutical firms are seeing orders move away from China, according to a publisher summary. The shift is being driven by Western buyers diversifying supply chains, with India helped by lower labour costs and local raw materials. The reporting also says some industry leaders still worry about reliance on Chinese imports for essential components, leaving supply risk unresolved.
Why it matters
Small and mid-sized Indian pharmaceutical firms are seeing orders shift away from China as Western buyers diversify supply chains, according to a publisher summary. India is benefiting from lower labour costs and access to local raw materials. Some industry leaders, however, still caution that essential components depend heavily on Chinese imports, so the supply-chain shift is not fully resolved.